A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT05970497 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Melanoma Stage III
Melanoma Stage IV
Cutaneous Melanoma

Interventions

BIOLOGICAL: KB707
DRUG: Opdualag
DRUG: KEYTRUDA ®( Pembrolizumab)

Sponsor

Krystal Biotech, Inc.